ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 23, 2012
Search Dividend Reports by Company Name: F to J
Search dividend reports by company name: F to J. As a supplement to our 16-page stock reports, our dividend reports assess the safety of a firm's dividend through our Valuentum Dividend Cushion ratio, the potential growth of a firm's dividend by evaluating its capacity and willingness to increase the dividend, the historical track record of the company's dividend performance, and the overall strength of the dividend by putting all of this analysis together. Each report offers our estimate of the future growth rate of the firm's dividend.
Aug 23, 2012
Search Dividend Reports by Company Name: A to E
Search dividend reports by company name: A to E. As a supplement to our 16-page stock reports, our dividend reports assess the safety of a firm's dividend through our Valuentum Dividend Cushion ratio, the potential growth of a firm's dividend by evaluating its capacity and willingness to increase the dividend, the historical track record of the company's dividend performance, and the overall strength of the dividend by putting all of this analysis together. Each report offers our estimate of the future growth rate of the firm's dividend.
Aug 15, 2012
Valuentum's August Edition of Its Best Ideas Newsletter! Our Best Ideas Portfolio Hits Record High
The August edition of our Best Ideas Newsletter is now available.
Aug 8, 2012
FAQ: How frequently are the (stock) reports updated and what triggers an update?
We answer one of the most frequently asked questions about our publishing cycle.
Aug 1, 2012
EDAC Posts 2Q Adjusted EPS of $0.31; Expects Huge Pratt Order in Back Half
Best Idea EDAC Tech posted excellent second-quarter results and hinted at a massive order in its pipeline.
Aug 1, 2012
Valuentum's August Edition of Its Dividend Growth Newsletter!
The August edition of our Dividend Growth Newsletter is now available.
Jul 31, 2012
Pfizer Reports Decent Second Quarter Results; Plans to Spin Off Animal Health Business
Pfizer posted decent second-quarter results that showed strong cost containment in the face of declining sales of its blockbuster drug Lipitor. The company also announced plans to spin off its animal health business to focus on its core pharma business. We maintain our view that Pfizer is significantly underpriced.
Jul 26, 2012
Alert: Facebook Tumbles in After-Hours Trading
Facebook posted disappointing second-quarter results in its first earnings report since going public. The firm continues to converge to our $20 per share fair value estimate.
Jul 24, 2012
Private Equity Consortium Said To Be In Talks to Take Ancestry.com Private in Deal Priced in the Mid-to-High $30s
According to the NYTimes DealBook, Best Idea Ancestry.com is in discussions with a private-equity consortium to take itself private at a price in the mid-to-high $30s, a 45% premium to its Tuesday closing price at the high end of the range.
Jul 22, 2012
A Note to Our Members
We discuss a few improvements to Valuentum's website that members should expect in coming days.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.